Equities

Lumibird SA

Lumibird SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)7.30
  • Today's Change0.000 / 0.00%
  • Shares traded6.67k
  • 1 Year change-44.27%
  • Beta1.3393
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LUMIBIRD SA is a French based company involved in the laser technology. The Company designs, manufactures and distributes high-performance lasers for scientific (research laboratories and universities), industrial (production, defense/space, Lidar sensors), Transport mapping, clean energy, and medical (ophthalmology) uses. The Company products are solid-state lasers, laser diode and components, Fiber lasers and fiber amplifiers, High power fiber lasers. The Company founded in 1997, and it has 15 subsidiaries.

  • Revenue in EUR (TTM)203.56m
  • Net income in EUR7.13m
  • Incorporated1974
  • Employees1.05k
  • Location
    Lumibird SA2 rue du Paul SabatierLANNION 22300FranceFRA
  • Phone+33 169291700
  • Fax+33 169291729
  • Websitehttps://www.lumibird.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AbL Diagnostics SA5.90m184.66k46.09m17.00249.566.7252.277.810.01150.01150.36640.42540.3942--1.61368,863.101.233.242.144.43----3.138.811.92-64.060.3109---35.8474.86-95.08-49.307.81--
Carmat SA5.53m-53.35m47.83m162.00------8.65-1.76-1.760.1787-0.64190.09321.611.2830,379.12-89.92-76.92-113.71-94.38-535.50---964.91-4,636.641.69-17.371.63--710.72---0.3502--16.99--
Median Technologies SA21.84m-25.35m63.25m250.00------2.90-1.29-1.291.11-1.190.7873-30.313.5790,227.27-91.41-54.57---157.51105.00101.57-116.10-93.700.6879-138.584.77---6.1028.52-13.70--38.38--
Affluent Medical SAS0.00-17.04m65.30m66.00--2.11-----0.5338-0.53380.000.78640.00----0.00-28.43---34.69-------------24.620.3586-------2.80------
Amplitude Surgical SA106.02m1.53m146.94m428.0096.171.5310.491.390.03180.03182.212.000.38890.53878.20247,707.900.56050.44120.66870.5279.3677.841.441.281.090.69590.5503--5.810.6658-96.11--2.62--
Lumibird SA203.56m7.13m164.01m1.05k20.510.84686.700.80570.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
Guerbet SA826.24m32.76m332.46m2.92k10.480.85333.720.40242.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Data as of Nov 22 2024. Currency figures normalised to Lumibird SA's reporting currency: Euro EUR

Institutional shareholders

13.58%Per cent of shares held by top holders
HolderShares% Held
Amiral Gestion SAas of 01 Mar 2024657.41k2.93%
Lazard Fr�res Gestion SASas of 28 Mar 2024553.43k2.46%
Herald Investment Management Ltd.as of 31 Dec 2023437.64k1.95%
Financi�re Arbevel SAas of 30 Dec 2022304.73k1.36%
Financi�re Tiepolo SASas of 29 Dec 2023237.77k1.06%
AXA Investment Managers (Paris) SAas of 30 Sep 2024235.60k1.05%
Amundi Asset Management SA (Investment Management)as of 30 Sep 2024181.31k0.81%
DNCA Finance SAas of 31 Mar 2023164.58k0.73%
BFT Investment Managers SAas of 30 Sep 2024150.24k0.67%
Cr�dit Mutuel Asset Management SAas of 28 Mar 2024128.00k0.57%
More ▼
Data from 29 Dec 2023 - 13 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.